LAG3, Human (Ieramilimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-LAG3, Human (Ieramilimab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityLAG3, Human (Ieramilimab biosimilar)
CloneIeramilimab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human LAG3 Recombinant Antibody. Ieramilimab (development code LAG525) is a monoclonal antibody being developed by Novartis for the treatment of cancer. The antibody targets the immune checkpoint LAG-3, which is expressed on T cells and tends to down-regulate an immune response. In a June 2015 presentation Novartis management indicated that 'dosing is imminent' for the first clinical trials of LAG525.
Immunogenn/a
Other NamesAnti-LAG3 Recombinant Antibody, Research Grade Ieramilimab, Anti-Human LAG3 Recombinant Antibody, LAG-525, Antibody Drug Analogues, Monoclonal Antibody, YR1554, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 2137049-37-5
Catalog #YR1554
Priceplease inquire
Order / More InfoLAG3, Human (Ieramilimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.